We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Lung Ultrasound Identifies Patients with Coronavirus

By MedImaging International staff writers
Posted on 06 Apr 2020
Print article
A new study outlines four brief acquisition protocols for performing lung ultrasonography on patients with COVID-19.

The protocols, developed at the University of Pavia (Italy), Valle del Serchio General Hospital (Lucca, Italy), the University of Trento (Italy), and other institutions outline the best probe to use, where clinicians should look for artifacts, where to set the focus, and how to visualize the widest surface possible with one scan. The protocols are based on finding that COVID-19 patients develop thickened pleura, B-lines, subpleural consolidations, and other hallmark lung ultrasound artifacts.

The four acquisition protocols include the following recommendations:
• Use of linear probes, as these can best capture the detail of pleural and subpleural artifacts; convex probes are also appropriate.
• Using a single focal point modality at the pleural line, instead of focusing at multiple locations.
• Scans should preferably be performed in intercostal spaces, as opposed to an orthogonal view of the ribs. This enables clinicians to see the widest surface possible with one scan.
• Artifacts should be looked for in multiple areas and bilaterally to see the extent of the affected lung surface, specifically in the apical, medial, and basal sections of the anterior midclavicular and posterior paraspinal sections, and in the apical and basal lateral axillary areas.

The study was published on March 20, 2020, in the Journal of Ultrasound in Medicine.

“Lung ultrasound can be used for triaging patients before hospital admission, monitoring emergency department patients with pneumonia, managing ventilation and weaning for intensive care unit patients, and evaluating the effects of antiviral medications,” concluded lead author Gino Soldati MD, of the ultrasound unit at Valle del Serchio General Hospital, and colleagues. “This is because ultrasound can identify changes in the ratio between air, tissue, and fluid in the lungs of patients with COVID-19.”

While CT has excellent ability to detect COVID-19, the modality can't be used at patients' bedsides and it puts additional medical staff at risk for virus exposure. As a result, some doctors in China, Spain, and Italy have turned to lung ultrasound as an alternative imaging modality.

Related Links:
University of Pavia
University of Trento


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Under Table Shield
3 Section Double Pivot Under Table Shield
Radiology Software
MSK Radiology
Dose Calibration Electrometer
PC Electrometer

Print article

Channels

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.